首页> 外文期刊>ACS applied materials & interfaces >Smart pH/Redox Dual-Responsive Nanogels for On-Demand Intracellular Anticancer Drug Release
【24h】

Smart pH/Redox Dual-Responsive Nanogels for On-Demand Intracellular Anticancer Drug Release

机译:智能pH /氧化还原双重响应纳米凝胶按需释放细胞内抗癌药物

获取原文
获取原文并翻译 | 示例
       

摘要

Efficient accumulation and intracellular drug release in cancer cells remain a crucial challenge in developing ideal anticancer drug delivery systems. Here, poly(N-isopropylacrylamide)-ss-acrylic acid (P(NIPAM-ss-AA)) nanogels based on NIPAM and AA cross-linked by N,N'-bis(acryloyl)cystamine (BAC) were constructed by precipitation polymerization. The nanogels exhibited pH/redox dual responsive doxorubicin (DOX) release behavior in vitro and in tumor cells, in which DOX release from nanogels was accelerated in lysosomal pH (pH 4.5) and cytosolic reduction (10 mM GSH) conditions. Moreover, intracellular tracking of DOX-loaded nanogels confirmed that after the nanogels and the loaded DOX entered the cells simultaneously mainly via lipid raft/caveolae-mediated endocytosis, DOX-loaded nanogels were transported to lysosomes and then the loaded DOX was released to nucleus triggered by lysosomal pH and cytoplasmic high GSH. MTT analysis showed that DOX-loaded nanogels could efficiently inhibit the proliferation of HepG2 cells. In vivo animal studies demonstrated that DOX-loaded nanogels were accumulated and penetrated in tumor tissues more efficiently than free DOX. Meanwhile, DOX-loaded nanogels exhibited stronger tumor inhibition activity and fewer side effects. This study indicated that pH/redox dual-responsive nanogels might present a prospective platform for intracellular drug controlled release in cancer therapy.
机译:在开发理想的抗癌药物递送系统中,癌细胞中的有效积累和细胞内药物释放仍然是至关重要的挑战。在这里,通过沉淀构建了基于NIPAM和AA的聚(N-异丙基丙烯酰胺)-ss-丙烯酸(P(NIPAM-ss-AA))纳米凝胶,通过N,N'-双(丙烯酰基)胱胺(BAC)交联聚合。纳米凝胶在体外和肿瘤细胞中均表现出pH /氧化还原双重反应性阿霉素(DOX)释放行为,其中溶酶体pH(pH 4.5)和胞质减少(10 mM GSH)条件下,纳米凝胶中DOX的释放被加速。此外,对DOX负载的纳米凝胶的细胞内跟踪证实,在纳米凝胶和负载的DOX主要通过脂质筏/微孔介导的内吞作用同时进入细胞后,将负载DOX的纳米凝胶转运至溶酶体,然后将负载的DOX释放至核触发通过溶酶体pH和细胞质高谷胱甘肽。 MTT分析表明,载有DOX的纳米凝胶可有效抑制HepG2细胞的增殖。体内动物研究表明,与游离DOX相比,装载DOX的纳米凝胶更有效地积累和渗透到肿瘤组织中。同时,载有DOX的纳米凝胶表现出更强的肿瘤抑制活性和更少的副作用。这项研究表明,pH /氧化还原双重反应纳米凝胶可能为癌症治疗中细胞内药物控制释放提供一个前瞻性平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号